Skip to main content
Clinical Trials/NCT01516801
NCT01516801CompletedNot Applicable

A Pragmatic Randomized Trial of the Effect of a Mailed Patient Flyer About PSA Testing Prior to an Annual Exam

University of Colorado, Denver1 site in 1 country303 target enrollmentStarted: October 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
303
Locations
1
Primary Endpoint
Rate of PSA testing

Study Overview

Brief Summary

  1. Does a one-page American College of Physicians educational flyer about the pros and cons of prostate cancer screening sent to men within two weeks of their scheduled annual health examinations in a general medicine clinic result in a different rate of prostate cancer screening than among men who were not sent the flyer?
  2. Do patients find the flyer useful and understandable?

Context: The use of prostate specific antigen (PSA) screening for prostate cancer is controversial because of a lack of evidence that such screening saves lives when applied within a population and because such testing can lead to invasive downstream biopsies and aggressive treatment that is associated with a high risk of permanent side effects (e.g. impotence, incontinence). Almost all professional societies (American Cancer Society, American Urologic Association, American College of Physicians, United States Preventive Services Task Force) advocate that patients receive education and complete an informed decision-making discussion with their medical providers about the pros and cons of the PSA test, as well as their personal preferences, before proceeding with this test. Unfortunately, despite these recommendations, there is seldom sufficient time during clinic visits to achieve this goal.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
50 Years to 74 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Men age 50-74 who were cared for in a general internal medicine clinic
  • •had scheduled an annual health exam
  • •had not had a PSA test within the previous year

Exclusion Criteria

  • •active cancer diagnosis
  • •history of prostate cancer
  • •need for PSA surveillance

Arms & Interventions

PSA flyer

Experimental

Intervention: PSA flyer (Other)

Control

No Intervention

Outcomes

Primary Outcomes

Rate of PSA testing

Time Frame: At the time of the annual exam (within two weeks of their annual physical)

Rate of PSA testing will be determined by reviewing the chart of enrolled patients within two weeks of their annual physical

Rate of documented PSA discussions

Time Frame: At the time of the annual exam (within two weeks of their annual physical)

Rate of documented PSA discussions will be determined through chart review within two weeks of the annual physical.

Secondary Outcomes

  • Flyer acceptability(Within two weeks of the annual exam)
  • Perceived participation(Within two weeks)
  • Prostate Cancer Screening knowledge(Within two weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials